Eam Investors, LLC Deciphera Pharmaceuticals, Inc. Transaction History

Eam Investors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $685,715 - $1.12 Million	55,389 New	55,389 $1.03 Million
Q1 2020 May 13, 2020	SELL	$33.63 - $69.4 $1.96 Million - $4.05 Million	-58,404 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$31.7 - $69.93 $1.85 Million - $4.08 Million	58,404 New	58,404 $3.64 Million
Q4 2018 Feb 13, 2019	SELL	$19.08 - $36.14 $1.54 Million - $2.91 Million	-80,580 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$33.57 - $42.1 $149,252 - $187,176	-4,446 Reduced 5.23%	80,580 $3.12 Million
Q2 2018 Aug 03, 2018	BUY	$20.06 - $44.95 $1.71 Million - $3.82 Million	85,026 New	85,026 $3.35 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.